Nanjing

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hepatitis B3 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Ausper Biopharma Co., Ltd.3 trials

Running trials

• Recruiting

  A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B

  NCT07635186· Phase 2· Ausper Biopharma Co., Ltd.· Source

  Contact: Lu

• Recruiting

  Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

  NCT07146100· Ausper Biopharma Co., Ltd.· Source

  Contact: Lu

• Active, not recruiting

  Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

  NCT07246889· Phase 3· Ausper Biopharma Co., Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B2 recruiting